Wednesday 16 October 2019

Tech firms create 300 new jobs

Enterprise Minister Richard Bruton
Enterprise Minister Richard Bruton

Ralph Riegel

IRELAND celebrated a 300 job boost thanks to two major technology investments.

Enterprise Minister Richard Bruton hailed the jobs as “a great day for Ireland” and proof that the economy remains very attractive for high-tech investment.

US pharmaceutical firm, BioMarin, is recruiting 100 staff as part of their roll-out of a new Cork plant which will make drugs for the treatment of rare diseases.

The BioMarin plant, developed in a Ringaskiddy, Co Cork facility earmarked for shutdown by Pfizer in 2009, already has 50 positions filled with a further 50 recruits to be in place by 2015.

The investment has also created 65 construction jobs.

BioMarin’s Cork development represents the first time the firm has invested outside the US.

A further 200 jobs will be created by a new €30m Irish Photonic Integration Centre (IPIC) which is being created within the Tyndall Institute in Cork.

The complex was described by former Tanaiste Mary Harney as Ireland’s “truly world-class R&D centre.”

The IPIC centre aims to help create 200 jobs within the photonic or light-energy sector by 2020.

The sector globally is estimated to be worth €58bn.

Research Minister Sean Sherlock said the IPIC investment is a strategic achievement for Ireland.

"This investment of €20m of taxpayers' money, with an additional €10m from industry, is further proof of the Government's commitment to Irish research. IPIC represents one of the strongest research teams in Europe,” he said.

“The centre is in prime position to achieve further funding from the Horizon

2020 funding round and to attract new companies and talent to Ireland.”

Mr Bruton said the BioMarin investment was a major morale boost for the pharmaceutical industry which represents a crucial element of the Irish export economy.

“Biopharma is a really exciting new area of pharmaceuticals and this is a really good story both for the firm and Ireland,” he said.

“They picked Cork and Ireland as the location for their investment…when Pfizer decided to close this plant there was obviously great disappointment in 2009. But the IDA and Government put every effort into finding another investor and that has been delivered here today.”

“BioMarin are now going into their growth phase. Not only are they creating the 100 jobs they committed to but they are now growing and they see Ireland as a global base for growth.”

Online Editors

Also in Business